• CF Resources

  Recent Vertex News VX-445

  Posted by luisa-palazola on June 3, 2019 at 2:03 pm

  Vertex recently announced their decision on which drug will be used from the triple combination trials. Between VX-445 and VX-659, VX-445 is moving forward with for FDA approval.

  Are you eligible for this drug? Have you used any CFTR modulators in the past?

  https://investors.vrtx.com/news-releases/news-release-details/vertex-selects-triple-combination-regimen-vx-445-tezacaftor-and?fbclid=IwAR0YM7RHfeq3l2k2wLqNzP8QJxM_gl1XLUTpLQNClNaTkk1OcBbgl6mPH48

  luisa-palazola replied 4 years, 10 months ago 1 Member · 0 Replies

  • cfscience
  • CFTR modulators
  • cystic fibrosis
  • triple combination
  • vertex
• 0 Replies

Log In to Reply